Teva Pharmaceutical Industries

Teva Pharmaceutical Industries TEVA Stock

$39.23   1.790340%
Add to favorites
Exchange
Market Cap
$45.77B
LOW - HIGH [24H]
$38.30 - $39.91
VOLUME [24H]
$6.81M
P/E Ratio
91.23
Earnings per share
$0.43
ISIN
US8816242098
Price   Prediction

Teva Pharmaceutical Industries Price Chart

Sorry, that's all we've gotfor now...

Teva Pharmaceutical Industries (TEVA) stock price today is 39.23 USD on NYSE (+1.79% on the day). Updated .

Teva Pharmaceutical Industries TEVA Financial and Trading Overview

Teva Pharmaceutical Industries stock price 39.23 USD
Previous Close 38.54 USD
Open 38.46 USD
Bid 39.26 USD x 70000
Ask 39.29 USD x 20000
Day's Range 38.3 - 39.91 USD
52 Week Range 24.01 - 44.57 USD
Volume 6.81M USD
Avg. Volume 6.27M USD
Market Cap 45.77B USD
Beta (5Y Monthly) 0.842
PE Ratio (TTM) 91.23256
EPS (TTM) 0.43 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date November 28, 2017
1y Target Est 50.51 USD

TEVA Valuation Measures

Enterprise Value 57.89B USD
Trailing P/E 91.23256
Forward P/E 12.529783
PEG Ratio (5 yr expected) 0.71
Price/Sales (ttm) 2.656681
Price/Book (mrq) 5.7370577
Enterprise Value/Revenue 3.36
Enterprise Value/EBITDA 13.141

Trading Information

Teva Pharmaceutical Industries Stock Price History

Beta (5Y Monthly) 0.842
52-Week Change 59.19%
S&P500 52-Week Change 8.67%
52 Week High 44.57 USD
52 Week Low 24.01 USD
50-Day Moving Average 40.58 USD
200-Day Moving Average 35.23 USD

TEVA Share Statistics

Avg. Volume (3 month) 6.27M USD
Avg. Daily Volume (10-Days) 7.71M USD
Shares Outstanding 1.17B
Float 1.09B
Short Ratio 4.49
% Held by Insiders 0.48%
% Held by Institutions 69.45%
Shares Short 27.74M
Short % of Float 2.39%
Short % of Shares Outstanding 2.38%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield 179.00%
Payout Ratio 0
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 2.93%
Operating Margin (ttm) 19.84%
Gross Margin 53.51%
EBITDA Margin 25.56%

Management Effectiveness

Return on Assets (ttm) 5.35%
Return on Equity (ttm) 6.65%

Income Statement

Revenue (ttm) 17.23B USD
Revenue Per Share (ttm) 14.87 USD
Quarterly Revenue Growth (yoy) -1.89%
Gross Profit (ttm) 9.22B USD
EBITDA 4.41B USD
Net Income Avi to Common (ttm) 506M USD
Diluted EPS (ttm) 0.43
Quarterly Earnings Growth (yoy) -46.20%

Balance Sheet

Total Cash (mrq) 4.08B USD
Total Cash Per Share (mrq) 3.5 USD
Total Debt (mrq) 17B USD
Total Debt/Equity (mrq) 212.9 USD
Current Ratio (mrq) 0.947
Book Value Per Share (mrq) 6.838

Cash Flow Statement

Operating Cash Flow (ttm) 1.77B USD
Levered Free Cash Flow (ttm) 1.49B USD

Profile of Teva Pharmaceutical Industries

Country United States
State N/A
City Tel Aviv-Yafo
Address 124 Dvora HaNevi’a St.
ZIP 6944020
Phone 972 3 914 8213
Website https://www.tevapharm.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 31173

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Q&A For Teva Pharmaceutical Industries Stock

What is a current TEVA stock price?

Teva Pharmaceutical Industries TEVA stock price today per share is 39.23 USD.

How to purchase Teva Pharmaceutical Industries stock?

You can buy TEVA shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Teva Pharmaceutical Industries?

The stock symbol or ticker of Teva Pharmaceutical Industries is TEVA.

Which industry does the Teva Pharmaceutical Industries company belong to?

The Teva Pharmaceutical Industries industry is Drug Manufacturers - Specialty & Generic.

How many shares does Teva Pharmaceutical Industries have in circulation?

The max supply of Teva Pharmaceutical Industries shares is 1.17B.

What is Teva Pharmaceutical Industries Price to Earnings Ratio (PE Ratio)?

Teva Pharmaceutical Industries PE Ratio is 91.23256000 now.

What was Teva Pharmaceutical Industries earnings per share over the trailing 12 months (TTM)?

Teva Pharmaceutical Industries EPS is 0.43 USD over the trailing 12 months.

Which sector does the Teva Pharmaceutical Industries company belong to?

The Teva Pharmaceutical Industries sector is Healthcare.

Teva Pharmaceutical Industries TEVA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us NYSE Arca Pharmaceutical Index DRG US 1315.95 USD —
+0.14
— — 1312.54 USD — 1336.79 USD — — — —
us NYSE Composite Index NYA US 22657.82 USD —
-2.08
— — 22604.5 USD — 23257.45 USD — — — —
us Better Investing 100 BIXX US 245.36 USD —
0
— — — — — — — — —
$2.05T
Total marketcap
$79.87B
Total volume
BTC 57.68%   •   ETH 9.85%
Dominance
Select currency